Abbott enters laser cataract surgery market with OptiMedica acquisition

Abbott Medical Optics (NYSE: ABT; Abbott Park, Illinois) has entered into an agreement to acquire ophthalmic device company OptiMedica (Santa Clara, CA), enabling Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market. Under the agreement, Abbott will acquire the company for $250 million, plus additional payments totaling up to $150 million upon completion of certain development, regulatory, or sales milestones.

Related: Laser cataract surgery: Clearly advanced

Related: OCT-enabled systems okayed for clinical use

OptiMedica's FDA- and CE Mark-approved Catalys Precision Laser System replaces some of the technically demanding manual steps in cataract surgery for removal of the crystalline lens with a computer-guided femtosecond laser technology. A femtosecond laser can be used to create anterior capsulotomy (opening of the lens capsule), effect phacofragmentation (softening of the lens nucleus), or make a variety of incisions during ocular surgery. Also, the system's integrated 3D optical coherence tomography (OCT) technology provides imaging of the anterior chamber of the eye, supporting safe and accurate preparation of the lens capsule for precise positioning of IOLs.

The transaction is expected to close by the end of 2013 and will not impact Abbott's ongoing full-year 2013 earnings-per-share guidance. The transaction is subject to customary closing conditions, including antitrust clearances.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World